FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Vitae Enim Vitae Scientific TETRACAINE 1% Tetracaine HCI Injection Recall

TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vi…

Vitae Enim Vitae Scientific, Inc. · San Diego, CA

Risk level
Class II
Reported by FDA
Apr 13, 2022
Recall ID
D-0741-2022
Check your lot numberHow we source this data

Summary

Vitae Enim Vitae Scientific recalled TETRACAINE 1% Tetracaine HCI Injection starting Mar 14, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0741-2022 on Apr 13, 2022. Reason: Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Product description

TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vials per box, Rx only, Manufactured for Cameron Pharmaceuticals, LLC., NDC 42494-437-10.

Lot numbers, UPCs & expiration codes

Lot #: 21VTHI017, 21VTHI018, 21VTHI019, Exp 5/31/2023

Where it was sold

Nationwide in the U.S.A

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0741-2022
Classification
Class II
Status
Terminated
Recall initiated
Mar 14, 2022
FDA report date
Apr 13, 2022
Quantity
722 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Vitae Enim Vitae Scientific, Inc.

Original FDA data

Every field from FDA enforcement report D-0741-2022, exactly as published.

Show all FDA fields
City
San Diego
State
CA
Status
Terminated
Country
United States
Event ID
89803
Address
3030 Bunker Hill St Ste 203
Code information
Lot #: 21VTHI017, 21VTHI018, 21VTHI019, Exp 5/31/2023
Postal code
92109-5754
Report date
Apr 13, 2022
Product type
Drugs
Recall number
D-0741-2022
Classification
Class II
Recalling firm
Vitae Enim Vitae Scientific, Inc.
Product quantity
722 boxes
Termination date
Aug 15, 2024
Reason for recall
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Voluntary / mandated
Voluntary: Firm initiated
Product description
TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vials per box, Rx only, Manufactured for Cameron Pharmaceuticals, LLC., NDC 42494-437-10.
Distribution pattern
Nationwide in the U.S.A
Recall initiation date
Mar 14, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Apr 5, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0741-2022, published Apr 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls